Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Soluble Factors in Progressive Multiple Sclerosis Pathology
FY 2022-23
Summary
Multiple sclerosis (MS) is a debilitating autoimmune disorder that affects the central nervous system. In MS, the immune system aberrantly attacks the myelin sheath surrounding neurons, causing significant injury. There are only two therapies currently available for patients living with the progressive form of MS (PMS), both of which have limited efficacy in PMS compared to relapsing-remitting disease (RRMS). The reason behind this difference is currently obscure. In hopes of clarifying the mechanisms behind PMS, my proposal will confront how soluble factors and immune cells in the brain impact inflammation and neurodegeneration in PMS compared to RRMS. I will focus specifically on the hippocampus and the meninges. The hippocampus is an important area of our brains responsible for memory and recollection, and past investigations have found critical damage to the hippocampus in PMS patients. This may be the cause of the cognitive decline commonly seen in PMS, which often includes memory impairment. The meninges overlays the brain, including the hippocampus, as protective membranes. Previously, inflammatory immune structures have been discovered in the meninges in patients with PMS. I hypothesise that these inflammatory structures in the meninges are a source of soluble factors that diffuse into parts of the brain like the hippocampus, causing demyelination and damage to neurons. In order to explore this theory, I will employ a technique at the frontiers of examining tissues in high definition: imaging mass cytometry. I will also validate my findings in novel animal models of MS developed in the lab. My work has the potential to rationalise new approaches for PMS therapies, expanding the presently limited range of care.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
486071
Name
Xie Qiao
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Soluble Factors in Progressive Multiple Sclerosis Pathology
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Autoimmunity; Complement System; Hippocampus; Imaging Mass Cytometry; Inflammation; Microglia; Multiple Sclerosis; Neurodegeneration; Synaptic Pruning; Tertiary Lymphoid Tissues
Abstract
Multiple sclerosis (MS) is a debilitating autoimmune disorder that affects the central nervous system. In MS, the immune system aberrantly attacks the myelin sheath surrounding neurons, causing significant injury. There are only two therapies currently available for patients living with the progressive form of MS (PMS), both of which have limited efficacy in PMS compared to relapsing-remitting disease (RRMS). The reason behind this difference is currently obscure. In hopes of clarifying the mechanisms behind PMS, my proposal will confront how soluble factors and immune cells in the brain impact inflammation and neurodegeneration in PMS compared to RRMS. I will focus specifically on the hippocampus and the meninges. The hippocampus is an important area of our brains responsible for memory and recollection, and past investigations have found critical damage to the hippocampus in PMS patients. This may be the cause of the cognitive decline commonly seen in PMS, which often includes memory impairment. The meninges overlays the brain, including the hippocampus, as protective membranes. Previously, inflammatory immune structures have been discovered in the meninges in patients with PMS. I hypothesise that these inflammatory structures in the meninges are a source of soluble factors that diffuse into parts of the brain like the hippocampus, causing demyelination and damage to neurons. In order to explore this theory, I will employ a technique at the frontiers of examining tissues in high definition: imaging mass cytometry. I will also validate my findings in novel animal models of MS developed in the lab. My work has the potential to rationalise new approaches for PMS therapies, expanding the presently limited range of care.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Xie, Qiao
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~